Kyasanur forest disease: a state-of-the-art review

QJM. 2022 Jun 7;115(6):351-358. doi: 10.1093/qjmed/hcaa310.

Abstract

Kyasanur forest disease (KFD) virus is a flavivirus that can be transmitted to humans from monkeys or other mammals through hard ticks (Haemaphysalis spinigera). The disease is endemic to 16 districts in 5 states of Southern India and is reported in the dry season, most commonly in humans travelling to the forests in these areas. The aim of this systematic review is to raise awareness of the clinical and laboratory manifestation of KFD among physicians and travel medicine practitioners. A total of 153 articles were screened of which 16 articles that met the inclusion and exclusion criteria were included for qualitative analysis. KFD is an acute haemorrhagic fever with a biphasic component in some individuals. The second phase is usually marked by neurological symptoms. Leucopoenia, thrombocytopenia and elevated transaminases are the hallmarks of the first phase of KFD. The diagnostic modality of choice in the first few days of illness is polymerase chain reaction assay, whereas serology is used in the late phase. In the absence of a specific antiviral treatment, the clinical management of patients is limited to supportive care. Avoidance of exposure and vaccination is recommended to prevent this infection.

Publication types

  • Systematic Review

MeSH terms

  • Animals
  • Encephalitis Viruses, Tick-Borne*
  • Humans
  • India / epidemiology
  • Ixodidae*
  • Kyasanur Forest Disease* / diagnosis
  • Kyasanur Forest Disease* / epidemiology
  • Kyasanur Forest Disease* / therapy
  • Leukopenia*
  • Mammals
  • Travel